13F Holdings
中文EN

PALX Palomino Laboratories Inc.

Semiconductors & Related Devices · OTC · SEC CIK 1938569 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-219.5%
TTM EPS YoY108.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-60.1%
ROA-55.5%
ROIC (approx.)-7,675.4%
Asset turnover—

Leverage & solvency

Liabilities / assets5.9%
Debt / equity0.00x
Current ratio18.90x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.61x
Accruals ratio-21.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31
Income statement
Revenue———
SG&A expense$2.70M$6,123$83,937
Operating income-$2.70M-$6,123-$83,937
Interest expense—$5,786—
Net income-$3.16M-$16,198-$83,937
EPS (basic)-0.47-0.01-0.02
EPS (diluted)-0.47-0.01-0.02
Weighted avg. shares (diluted)6.71M1.52M5.00M
Balance sheet
Cash & equivalents$8.12M$135,000$139,527
Current assets$8.43M$138,125$380
Total assets$8.43M$138,125$380
Current liabilities$337,000$6,431$111,621
Total liabilities$337,000$156,431$111,621
Shareholders' equity$8.10M-$17,000-$17,000
Shares outstanding18.77M4.50M5.00M
Cash flow statement
Operating cash flow-$1.28M-$4,870-$79,379
Financing cash flow$9.27M$195,437$79,259
Stock-based compensation$1.44M——

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.